Related Experiment Video
Updated: Jul 21, 2026
07:05
Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
Published on: September 10, 2018
Using cost-effectiveness analysis for formulary decision making: from theory into practice
1Departments of Health Administration and Medicine, University of Toronto, Ontario, Canada.
Pharmacoeconomics
|September 5, 1994
Summary
Cost-effectiveness analysis (CEA) helps healthcare payers assess the value of pharmaceutical products beyond price. Practical application of CEA requires changes for better decision-making.
Area of Science:
- Health Economics
- Pharmaceutical Policy
Background:
- Rising healthcare and pharmaceutical expenditures pose challenges for third-party payers due to limited market discipline.
- Cost-effectiveness analysis (CEA) offers a systematic approach for payers to evaluate the value for money of healthcare interventions and pharmaceutical products.
Purpose of the Study:
- To explore the transition of cost-effectiveness analysis from academic theory to practical application in healthcare decision-making.
- To identify necessary changes for the systematic adoption of CEA by formulary committees.
Main Methods:
- The study reviews the principles of cost-effectiveness analysis, emphasizing its comprehensive approach to costs and benefits over simple unit price comparisons.
- It discusses the practical implementation challenges and required adaptations for integrating CEA into formulary decision-making processes.
Main Results:
- The adoption of CEA by formulary committees necessitates defining its purpose, standardizing outcome measurement and data collection, and refining report formats.
- Contractual agreements between the pharmaceutical industry and analysts are crucial for practical CEA implementation.
Conclusions:
- The practical application of cost-effectiveness analysis in healthcare decision-making is evolving.
- Increased real-world experience with CEA will enhance data quality and its utility in guiding payer decisions, ultimately improving value for money in pharmaceutical procurement.
More Related Videos
Related Concept Videos
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
01:23Dosage Regimen Designs: Nomograms and Tabulations
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).